Olson Margaret E, Abate-Pella Daniel, Perkins Angela L, Li Ming, Carpenter Michael A, Rathore Anurag, Harris Reuben S, Harki Daniel A
Department of Medicinal Chemistry, ‡Department of Biochemistry, Molecular Biology & Biophysics, and §Masonic Cancer Center, University of Minnesota , 2231 Sixth Street SE, Minneapolis, Minnesota 55455, United States.
J Med Chem. 2015 Sep 24;58(18):7419-30. doi: 10.1021/acs.jmedchem.5b00930. Epub 2015 Sep 11.
High-throughput screening (HTS) was employed to discover APOBEC3G inhibitors, and multiple 2-furylquinolines (e.g., 1) were found. Dose-response assays with 1 from the HTS sample, as well as commercial material, yielded similar confirmatory results. Interestingly, freshly synthesized and DMSO-solubilized 1 was inactive. Repeated screening of the DMSO aliquot of synthesized 1 revealed increasing APOBEC3G inhibitory activity with age, suggesting that 1 decomposes into an active inhibitor. Laboratory aging of 1 followed by analysis revealed that 1 undergoes oxidative decomposition in air, resulting from a [4 + 2] cycloaddition between the furan of 1 and (1)O2. The resulting endoperoxide then undergoes additional transformations, highlighted by Baeyer-Villager rearrangements, to deliver lactam, carboxylic acid, and aldehyde products. The endoperoxide also undergoes hydrolytic opening followed by further transformations to a bis-enone. Eight structurally related analogues from HTS libraries were similarly reactive. This study constitutes a cautionary tale to validate 2-furylquinolines for structure and stability prior to chemical optimization campaigns.
采用高通量筛选(HTS)来发现载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G)抑制剂,并发现了多种2-呋喃基喹啉(如化合物1)。对高通量筛选样品中的化合物1以及市售材料进行剂量反应测定,得到了相似的验证结果。有趣的是,新合成并溶解于二甲基亚砜(DMSO)的化合物1没有活性。对合成的化合物1的DMSO等分试样进行反复筛选,结果显示其对APOBEC3G的抑制活性随时间增加,这表明化合物1分解成了一种活性抑制剂。对化合物1进行实验室老化处理后分析发现,化合物1在空气中会发生氧化分解,这是由于化合物1的呋喃与单线态氧(1O2)之间发生了[4 + 2]环加成反应。生成的内过氧化物随后会发生进一步转化,以拜耳-维利格重排反应为突出特征,生成内酰胺、羧酸和醛类产物。内过氧化物还会发生水解开环,随后进一步转化为双烯酮。来自高通量筛选文库的八个结构相关类似物也具有类似的反应活性。这项研究警示人们,在进行化学优化之前,要对2-呋喃基喹啉的结构和稳定性进行验证。